The 2013-2018 Outlook for Molecular Diagnostics in the United States

Icon Group International, Inc.
July 17, 2013
706 Pages - SKU: ICN5114931
Countries covered: United States

The 2013-2018 Outlook for Molecular Diagnostics in the United States

This econometric study covers the latent demand outlook for molecular diagnostics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates are created for molecular diagnostics. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the cities in the United States). This study gives, however, my estimates for the latent demand, or the P.I.E., for molecular diagnostics in the United States. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of the United States. For each state, I also show my estimates of how the P.I.E. grows over time. In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on strategic planning at graduate schools of business.



More Molecular Diagnostics reports by Icon Group International, Inc.

The 2013-2018 Outlook for Prenatal and New-Born Genetic Testing in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Prenatal and New-Born Genetic Testing in the United StatesThis econometric study covers the latent demand outlook for prenatal and new-born genetic ...
The 2013-2018 Outlook for Nucleic Acid Testing in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Nucleic Acid Testing in the United StatesThis econometric study covers the latent demand outlook for nucleic acid testing across the states ...
The 2013-2018 Outlook for Genetic Testing Services in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Genetic Testing Services in the United StatesThis econometric study covers the latent demand outlook for genetic testing services across the states ...
The 2013-2018 Outlook for Genetic Analysis Services in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Genetic Analysis Services in the United StatesThis econometric study covers the latent demand outlook for genetic analysis services across the states ...
See all reports like this >>

More United States Molecular Diagnostics reports

US Sales and Market Shares of Major Molecular Diagnostic Product Suppliers by VPGMarketResearch.com
US Sales and Market Shares of Major Molecular Diagnostic Product SuppliersThis unique report from Venture Planning Group provides US sales and market share estimates for ...
Molecular Diagnostics in Infectious Disease Testing by TriMark Publications
Molecular Diagnostics in Infectious Disease Testing This TriMark Publications report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics ...
Future Horizons and Growth Strategies in the US Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts by VPGMarketResearch.com
Future Horizons and Growth Strategies in the US Molecular Diagnostics Market 2014: Supplier Shares and Country Forecasts by VPGMarketResearch.com
This new 880-page report from Venture Planning Group contains 37 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including: Major issues ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 495  
    Global Site License  USD 990  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!